• X-Ray Inspection System

    Sunstein prosecutes patents for AS&E, an industry leader in advanced detection systems, which sells products employing sophisticated x-ray imaging technology used to inspect cargo and vehicles at ports of entry for explosives and contraband.

  • Programmable Switch

    Sunstein patents protect integrated circuits, such as the synchronous switch post rotator shown here, that our clients have developed for innovative applications in computer, automotive, manufacturing and testing industries.

  • iBOT® Mobility System

    For renowned inventor Dean Kamen, Sunstein obtained patents for the iBOT® Mobility System sold by Independence Technology (a division of Johnson & Johnson), which allows the physically challenged to climb stairs and traverse uneven terrain, and, notably, to raise themselves to the level of standing persons.

  • LAV Valve

    Sunstein won a jury verdict for Abbott Laboratories and NP Medical, defeating a multi-million dollar patent infringement claim relating to intravenous valve devices. The verdict and judgement of non-infringement were affirmed by the Court of Appeals for the Federal Circuit.

Deep Patent & Trial Experience

Ariad Pharmaceuticals, Inc. v. Eli Lilly and Co.

We participated in the representation of Ariad, obtaining a $65 million jury verdict for infringement of our client’s patents for regulating NF-kappaB cell-signaling activity, the largest verdict in Massachusetts that year.

Exergen Corporation vs. Kaz, USA, Inc.

Sunstein lawyers won a $14.6M verdict for patent infringement following a two-week jury trial for our client Exergen, the people who pioneered the temporal artery thermometer.

Comair Rotron v. Nippon Densan Corporation and Nidec Corporation

After securing a judgment of patent infringement, we negotiated a multimillion dollar settlement for our client Comair Rotron. The patent was directed to important magnetization technology for brushless DC electric motors.

In disputes over brand names, we have also delivered major successes to our clients.

Winning at Post Grant Proceedings

Motorola Mobility LLC, Google Inc., and Apple Inc. v. Arendi S.A.R.L.

Motorola, Google and Apple attacked the same patent as Samsung raising several additional grounds. Our arguments carried the day and the inter partes review was not instituted, freeing our client’s patent for unfettered assertion in court.

Click here to learn more about Sunstein litigators.

Spotlight on Patents

diagram1 For our client Dr. Leslie Stern of Fall River, Massachusetts, we recently obtained US Patent No. 8,460,310, describing a medical device for use in minimally invasive spine surgery.

In the News

Our Latest Thinking

  • Software inventions that improve computer functionality stand a better chance of passing the Supreme Court’s patent-eligibility test than software that merely implements well-known business practices.

    More...
  • Due to the broad reach of assignor estoppel, a company that sells a patent will often be barred from challenging its validity if the company is later sued for infringing that patent.

    More...
  • The Supreme Court has changed the calculus for litigants, making it easier for patentees who win at trial to recover enhanced damages, up to triple the amount awarded for infringement.

    More...
  • In inter partes reviews (IPRs), the parties must be given the chance to argue the validity of a challenged patent claim in the wake of any new claim construction that the Patent Trial and Appeal Board develops during the course of the proceeding.

    More...
  • Google copied 170 lines of Oracle’s code to enable the operability of Android apps on the popular Java platform. A jury has decided this was fair use under copyright laws.

    More...
  • The First Circuit has adapted a VCR-era statute to protect the privacy of mobile phone subscribers.

    More...
  • A trial court decision casts doubt on the value to retailers of “comprehensive” cybersecurity insurance policies. Some expensive consequences of a security breach may not be covered.

    More...

Free Subscription

See more in Publications/News